Industry: Pharmaceuticals, Biotechnology
Cellzome is a privately-owned drug discovery company applying its world-class technology towards the discovery and development of a pipeline of distinctive, small molecule, therapeutics targeted at , inflammatory diseases. A particular, patented, form of the technology, called KinobeadsÔ, enables the quantitative analysis of compounds interacting with their kinase targets, in active or inactive conformations, directly in relevant cells or tissues. Because no use is made of recombinant protein or labelling techniques, the technology offers advantages both in speeding up screening and selectivity profiling, especially for problematic targets, as well as the generation of data of superior physiological ( www.cellzome.com )
Cellzome AG
160 Centennial Ave Centennial Park
Elstree, Hertfordshire WD6 3SH
United Kingdom
Tel: +44 20 8238 6950
Fax: +44 20 82386951